Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 89 citing Meier: Secretion, degradation, and elimination of glucagon-like peptide 1 and gastric inhibitory.... (0.08 sec) 

Biology of incretins: GLP-1 and GIP

- rh.dk [PDF] 
LL Baggio, DJ Drucker - Gastroenterology, 2007 - Elsevier
This review focuses on the mechanisms regulating the synthesis, secretion,
biological actions, and therapeutic relevance of the incretin peptides
glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...
Cited by 179 - Related articles - All 25 versions

The physiology of glucagon-like peptide 1

- physiology.org
JJ Holst - Physiological reviews, 2007 - Am Physiological Soc
Glucagon-like peptide 1 (GLP-1) is a 30-amino acid peptide hormone produced in
the intestinal epithelial endocrine L-cells by differential processing of
proglucagon, the gene which is expressed in these cells. The current ...
Cited by 119 - Related articles - BL Direct - All 5 versions

Glucagon-like peptide 1 and its derivatives in the treatment of diabetes


MA Nauck, JJ Meier - Regulatory peptides, 2005 - Elsevier
Glucagon-like peptide 1 (GLP-1) was discovered as an insulinotropic gut hormone,
suggesting a physiological role as an incretin hormone, ie, being responsible,
in part, for the higher insulin secretory response after oral as compared ...
Cited by 107 - Related articles - All 6 versions

Inhibitors of dipeptidyl peptidase IV: a novel approach for the prevention and treatment of …


CF Deacon, B Ahrén, JJ Holst - eid, 2004 - informahealthcare.com
Inhibitors of the enzyme dipeptidyl peptidase IV (DPP IV) are of increasing
interest to both diabetologists and the pharmaceutical industry alike, as they
may become established as the next member of the oral antidiabetic class of ...
Cited by 102 - Related articles - All 7 versions

Therapeutic approaches to preserve islet mass in type 2 diabetes

- tufts.edu [PDF] 
LL Baggio, DJ Drucker, 2006 - Annual Reviews
Type 2 diabetes is characterized by hyperglycemia resulting from insulin
resistance in the setting of inadequate β-cell compensation. Currently
available therapeutic agents lower blood glucose through multiple ...
Cited by 78 - Related articles - BL Direct - All 10 versions

What do we know about the secretion and degradation of incretin hormones?


CF Deacon - Regulatory peptides, 2005 - Elsevier
The incretin hormones, glucose-dependent insulinotropic peptide (GIP) and
glucagon-like peptide-1 (GLP-1) are secreted from endocrine cells located in the
intestinal mucosa, and act to enhance meal-induced insulin secretion. GIP ...
Cited by 70 - Related articles - All 6 versions

Glucagon-like peptide 1 (GLP-1) in biology and pathology


JJ Meier, MA Nauck - Diabetes/Metabolism Reviews - interscience.wiley.com
Post-translational proteolytic processing of the preproglucagon gene in the gut
results in the formation of glucagon-like peptide 1 (GLP-1). Owing to its
glucose-dependent insulinotropic effect, this hormone was postulated to ...
Cited by 73 - Related articles - All 3 versions

Glucagon-like peptide 1 and inhibitors of dipeptidyl peptidase IV in the treatment of type 2 …


JJ Holst, CF Deacon - Current Opinion in Pharmacology, 2004 - Elsevier
Glucagon-like peptide 1 (GLP-1) is a 30 amino acid peptide secreted by
intestinal L-cells in response to meal ingestion. It functions as one of the
incretin hormones; that is, the gut hormones that enhance ...
Cited by 57 - Related articles - All 2 versions

Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination …


M Nauck, A Frid, K Hermansen, NS Shah, T … - Diabetes Care, 2009 - Am Diabetes Assoc
RESULTS—A1C values were significantly reduced in all liraglutide groups versus
the placebo group (P < 0.0001) with mean decreases of 1.0% for 1.8 mg
liraglutide, 1.2 mg liraglutide, and glimepiride and 0.7% for 0.6 mg ...
Cited by 49 - Related articles - All 4 versions

Plasticity of the β cell insulin secretory competence: preparing the pancreatic β cell for the …


SA Hinke, K Hellemans, FC Schuit - The Journal of physiology, 2004 - Physiological Soc
It is well established that the acute rise in plasma glucose and in the incretin
hormones glucose-dependent insulinotropic peptide (GIP) and glucagon-like
peptide-1 (7–36) amide (GLP-1), as occurs during a meal, is of pivotal ...
Cited by 26 - Related articles - All 9 versions


Result Page: 

1

2

3

4

5

6

7

8

9

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google